Kopran Ltd held its 67th Annual General Meeting on August 18, 2026, where all items were passed. Voting results and the Scrutinizer's Report were submitted.
Kopran Limited announced an NCLT-convened meeting on June 3, 2026, to approve the amalgamation of Kopran Laboratories Limited into the company. The merger will increase promoter shareholding from 44.43% to 55.33%. This consolidation aims to streamline the group structure and enhance operational efficiencies in the pharmaceutical and healthcare segments.